Pathological GBA mutations result in reducted glucocerebrosidase activity [36], and, importantly, PD patients without GBA mutations also exhibit lower levels of GCase activity in the central nervous system, further confirming the contribution of the gba gene to the disease pathogenesis [37,38]. The gene discussed is GBA1; the disease is Parkinson disease.